These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 29337460)
21. Epigenetics and methylation in the rheumatic diseases. Zufferey F; Williams FM; Spector TD Semin Arthritis Rheum; 2014 Apr; 43(5):692-700. PubMed ID: 24231066 [TBL] [Abstract][Full Text] [Related]
22. Autoimmunity and primary immunodeficiency: two sides of the same coin? Schmidt RE; Grimbacher B; Witte T Nat Rev Rheumatol; 2017 Dec; 14(1):7-18. PubMed ID: 29255211 [TBL] [Abstract][Full Text] [Related]
23. Epigenetics, pregnancy and autoimmune rheumatic diseases. Pacini G; Paolino S; Andreoli L; Tincani A; Gerosa M; Caporali R; Iagnocco A; Ospelt C; Smith V; Cutolo M Autoimmun Rev; 2020 Dec; 19(12):102685. PubMed ID: 33115633 [TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology. Ferraccioli G; De Santis M; Tolusso B Pharmacogenomics; 2004 Dec; 5(8):1107-16. PubMed ID: 15584877 [TBL] [Abstract][Full Text] [Related]
25. Perspectives from masters in rheumatology and autoimmunity: perspectives on the conventional wisdom. Fries JF Arthritis Rheumatol; 2015 Nov; 67(11):2806-12. PubMed ID: 25989060 [No Abstract] [Full Text] [Related]
26. [Dynamic developments in rheumatology]. Müller-Ladner U; Rüther W Dtsch Med Wochenschr; 2007 Sep; 132(37):1887. PubMed ID: 17823880 [No Abstract] [Full Text] [Related]
27. Immune Checkpoint Inhibitor Therapy in Patients With Autoimmune Disease. Johnson DB; Beckermann KE; Wang DY Oncology (Williston Park); 2018 Apr; 32(4):190-4. PubMed ID: 29684232 [TBL] [Abstract][Full Text] [Related]
29. Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature. Benfaremo D; Manfredi L; Luchetti MM; Gabrielli A Curr Drug Saf; 2018; 13(3):150-164. PubMed ID: 29745339 [TBL] [Abstract][Full Text] [Related]
31. Bibliography. Current world literature. Pediatric and heritable disorders. Curr Opin Rheumatol; 2004 Sep; 16(5):649-52. PubMed ID: 15382343 [No Abstract] [Full Text] [Related]
32. The genetics of autoimmune-mediated rheumatic diseases: clinical and biologic implications. Winchester R Rheum Dis Clin North Am; 2004 Feb; 30(1):213-27, viii. PubMed ID: 15061576 [TBL] [Abstract][Full Text] [Related]
33. Update on biosimilars in rheumatology. Rischin A; Östör AJ Inflammopharmacology; 2017 Apr; 25(2):177-184. PubMed ID: 28265837 [TBL] [Abstract][Full Text] [Related]
34. Cancer immunotherapy-induced rheumatic diseases emerge as new clinical entities. Cappelli LC; Shah AA; Bingham CO RMD Open; 2016; 2(2):e000321. PubMed ID: 27752360 [TBL] [Abstract][Full Text] [Related]
36. [Rheumatology--searching for the individual therapeutic cocktail]. Hellmich B; Lamprecht P; Gross WL Dtsch Med Wochenschr; 2005 Jun; 130(25-26):1555-8. PubMed ID: 15965861 [No Abstract] [Full Text] [Related]
37. [Basic directions in the development of Soviet scientific and practical rheumatology in the last 70 years]. Nasonova VA Ter Arkh; 1987; 59(10):12-7. PubMed ID: 3501616 [No Abstract] [Full Text] [Related]
38. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity. Long H; Yin H; Wang L; Gershwin ME; Lu Q J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525 [TBL] [Abstract][Full Text] [Related]
39. Overlap syndromes in the context of shared autoimmunity. Rodríguez-Reyna TS; Alarcón-Segovia D Autoimmunity; 2005 May; 38(3):219-23. PubMed ID: 16126510 [TBL] [Abstract][Full Text] [Related]